Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Teladoc Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.90 |
52 Week High | US$22.53 |
52 Week Low | US$6.50 |
Beta | 0.91 |
11 Month Change | 18.52% |
3 Month Change | -4.35% |
1 Year Change | -52.00% |
33 Year Change | -93.23% |
5 Year Change | -86.56% |
Change since IPO | -75.63% |
Recent News & Updates
Recent updates
Shareholder Returns
0LDR | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 4.9% | 0.2% | -0.8% |
1Y | -52.0% | 26.1% | 9.2% |
Return vs Industry: 0LDR underperformed the UK Healthcare Services industry which returned 26.1% over the past year.
Return vs Market: 0LDR underperformed the UK Market which returned 9.2% over the past year.
Price Volatility
0LDR volatility | |
---|---|
0LDR Average Weekly Movement | 9.0% |
Healthcare Services Industry Average Movement | 5.8% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 9.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0LDR's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0LDR's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 5,208 | Chuck Divita | www.teladochealth.com |
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Teladoc Health, Inc. Fundamentals Summary
0LDR fundamental statistics | |
---|---|
Market cap | US$1.55b |
Earnings (TTM) | -US$1.01b |
Revenue (TTM) | US$2.61b |
0.6x
P/S Ratio-1.5x
P/E RatioIs 0LDR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0LDR income statement (TTM) | |
---|---|
Revenue | US$2.61b |
Cost of Revenue | US$761.98m |
Gross Profit | US$1.85b |
Other Expenses | US$2.85b |
Earnings | -US$1.01b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -5.87 |
Gross Margin | 70.80% |
Net Profit Margin | -38.54% |
Debt/Equity Ratio | 102.6% |
How did 0LDR perform over the long term?
See historical performance and comparison